AMYRIS TO PARTICIPATE AT MAY INVESTOR CONFERENCES

EMERYVILLE, Calif., May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market^TM technology platform, today announced that management will participate in fireside chats at the following upcoming investor conferences. 

• Morgan Stanley Sustainable Futures Conference, May 23 at 2:00 PM ET (virtual)
• UBS Global Healthcare Conference, May 25 at 11:30 AM ET (in-person)

Live webcasts of the presentations and replays will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.

About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market^TM technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit https://www.amyris.com.

Amyris, the Amyris logo, Biossance, JVN, Lab-to-Market, OLIKA, Pipette, Purecane, and Rose Inc. are trademarks or registered trademarks of Amyris, Inc. or its subsidiaries in the U.S. and/or other countries.

View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-to-participate-at-may-investor-conferences-301552644.html

SOURCE Amyris, Inc.